Inhibition of malignant transformation in vitro by inhibitors of poly(ADP-ribose) synthesis
- PMID: 6582479
- PMCID: PMC344648
- DOI: 10.1073/pnas.81.1.243
Inhibition of malignant transformation in vitro by inhibitors of poly(ADP-ribose) synthesis
Abstract
Malignant transformation in vitro of hamster embryo cells and mouse C3H 10T 1/2 cells by x-rays, ultraviolet light, and chemical carcinogens was inhibited by benzamide and by 3-aminobenzamide at concentrations that are specific for inhibition of poly(ADP-ribose) formation. These compounds slow the ligation stage of repair of x-ray and alkylation damage but not of ultraviolet light damage. At high concentrations they also inhibited de novo synthesis of DNA purines and DNA methylation by S-adenosylmethionine. The suppression of transformation by the benzamides is in striking contrast to their reported effectiveness in enhancing sister chromatid exchange, mutagenesis, and killing in cells exposed to alkylating agents. Our results suggest that mechanisms regulating malignant transformation are different from those regulating DNA repair, sister chromatid exchange, and mutagenesis and may be associated with changes in gene regulation and expression caused by alterations in poly(ADP-ribosyl)ation.
Similar articles
-
Inhibition of X-ray- and ultraviolet light-induced transformation in vitro by modifiers of poly(ADP-ribose) synthesis.Radiat Res. 1984 Aug;99(2):219-27. Radiat Res. 1984. PMID: 6463203
-
Poly(ADP-ribose): spectator or participant in excision repair of DNA damage.Princess Takamatsu Symp. 1983;13:195-207. Princess Takamatsu Symp. 1983. PMID: 6686227
-
Methylating and ethylating carcinogens have different requirements for poly(ADP-ribose) synthesis during malignant transformation.Carcinogenesis. 1984 Dec;5(12):1573-6. doi: 10.1093/carcin/5.12.1573. Carcinogenesis. 1984. PMID: 6499109
-
Critical biochemical and regulatory events in malignant transformation in vitro.Princess Takamatsu Symp. 1983;14:195-206. Princess Takamatsu Symp. 1983. PMID: 6394589 Review.
-
Poly(ADP-ribose) synthesis is involved in the toxic effects of alkylating agents but does not regulate DNA repair.Mutat Res. 1985 Jun-Jul;150(1-2):69-76. doi: 10.1016/0027-5107(85)90102-2. Mutat Res. 1985. PMID: 3923344 Review.
Cited by
-
Tumor promoter phorbol-12-myristate-13-acetate induces poly(ADP)-ribosylation in fibroblasts.EMBO J. 1985 Jun;4(6):1491-4. doi: 10.1002/j.1460-2075.1985.tb03807.x. EMBO J. 1985. PMID: 4029121 Free PMC article.
-
Eukaryotic nuclear ADP-ribosylation reactions.Biochem J. 1985 Aug 15;230(1):1-18. doi: 10.1042/bj2300001. Biochem J. 1985. PMID: 2996490 Free PMC article. Review. No abstract available.
-
Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.Br J Pharmacol. 2018 Jan;175(2):192-222. doi: 10.1111/bph.13748. Epub 2017 Mar 26. Br J Pharmacol. 2018. PMID: 28213892 Free PMC article. Review.
-
Combination effects of poly(ADP-ribose) polymerase inhibitors and DNA-damaging agents in ovarian tumor cell lines--with special reference to cisplatin.J Cancer Res Clin Oncol. 1996;122(11):665-70. doi: 10.1007/BF01209029. J Cancer Res Clin Oncol. 1996. PMID: 8898976 Free PMC article.
-
ADP-ribosyltransferase is highly conserved: purification and characterization of ADP-ribosyltransferase from a fish and its comparison with the human enzyme.J Comp Physiol B. 1987;157(5):567-72. doi: 10.1007/BF00700976. J Comp Physiol B. 1987. PMID: 3121683
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources